Immune Tolerance Study With Aldurazyme® (Laronidase)

Clinical trial NCT00741338 · COMPLETED

Trial details

NCT number: NCT00741338
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mucopolysaccharidosis I

Start date: 2008-09-01
Primary completion: 2012-09-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.